About MSC
About Medical Scientific Consulting
MSC helps biotechnology, diagnostics, and healthcare technology companies navigate Japan’s complex healthcare ecosystem and accelerate successful market entry.
MSC is a next-generation consulting platform designed to accelerate market entry into Japan.
Japan requires more than localization. It requires alignment between science, regulation, clinical practice, and stakeholder expectations. We combine:
- Deep scientific expertise
- Direct access to Japanese KOL and site networks
- Practical PMDA and market access insight
- Lean execution models designed for emerging biotechs
Our approach is built on three principles:
Risk Identification
Clearly define what could go wrong without the right strategy.
Business Impact Translation
Translate scientific and regulatory decisions into business outcomes.
Execution Support
Deliver strategies that can be implemented in the real world.
These are grounded in real-world constraints, deep industry insight, and strong networks across Japan’s healthcare ecosystem.
We help our clients not only enter Japan—but succeed.
Credibility Elements – Satoshi Sugawa, PhD
Founder & Principal Consultant
Key Metrics
14+
years of Medical Affairs leadership
55+
Real World Evidence studies
400+
clinician and healthcare stakeholder network
40+
scientific publications
25+
academic partnerships across Japan
Industry Leadership
Extensive leadership experience across global healthcare and life sciences organizations, including:
- Pharming
- Thermo Fisher
- Abbott
- Mitsubishi Chemical
Led medical affairs, international business development, and strategic scientific initiatives across diagnostics, biotechnology, and rare diseases.
Japan Healthcare Network
Established network with 400+ leading Japanese clinicians, researchers, and healthcare stakeholders across:
- Cardiology
- Autoimmune diseases
- Primary immunodeficiencies
- Emergency medicine
- Infectious diseases
Long-standing collaborations with more than 25 national universities and major academic institutions throughout Japan.
Scientific & Clinical Expertise
Deep expertise in:
- Japan market entry strategy
- Real World Evidence (RWE)
- Clinical positioning
- PMDA-oriented development strategy
- In vitro diagnostics (IVD)
Successfully supported evidence generation and strategic planning for both global and Japan-focused healthcare initiatives.
International Research Background
Visiting Scientist at MIT specializing in cellular immunology and translational research.
Representative Engagements
- Rare Disease Launch Strategy
- Biomarker Evidence Generation
- IVD Market Development
- KOL Network Development
Full publication list available upon request.